دورية أكاديمية
أعرض في EDS

Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.

التفاصيل البيبلوغرافية
العنوان: Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
المؤلفون: Mirza FA; Department of Otolaryngology - Head and Neck Surgery, Medical College of Georgia at Augusta University, Augusta, Georgia, USA., Johnson CZ; Department of Otolaryngology - Head and Neck Surgery, Medical College of Georgia at Augusta University, Augusta, Georgia, USA., Byrd JK; Department of Otolaryngology - Head and Neck Surgery, Medical College of Georgia at Augusta University, Augusta, Georgia, USA., Albergotti WG 3rd; Department of Otolaryngology - Head and Neck Surgery, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
المصدر: Head & neck [Head Neck] 2021 Nov; Vol. 43 (11), pp. 3476-3492. Date of Electronic Publication: 2021 Sep 09.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE
أسماء مطبوعة: Publication: New York, NY : John Wiley And Sons
Original Publication: New York, NY : J. Wiley, c1989-
مواضيع طبية MeSH: Alphapapillomavirus* , Head and Neck Neoplasms* , Oropharyngeal Neoplasms*/surgery , Papillomavirus Infections*/epidemiology, Humans ; Papillomaviridae ; Squamous Cell Carcinoma of Head and Neck
مستخلص: Background: Given recent increase in prevalence of oropharyngeal squamous cell carcinoma (OPSCC) and advances in surgical capabilities, we sought to determine whether a change in frequency of surgery-based treatment for locally advanced OPSCC has occurred.
Methods: Patients with T3-T4b OPSCC in the National Cancer Database diagnosed from 2010 to 2016 were categorized as receiving primary surgery or radiation-based therapy and stratified by human papillomavirus (HPV) status. Trends in treatment selection and factors associated with treatment type were examined.
Results: 6566 patients with HPV-positive were included, of whom 489 (7.45%) received surgery and 4698 patients with HPV-negative, of whom 362 (7.71%) received surgery. The percentage of patients treated with surgery decreased from 11.8% to 5.9% for HPV-positive disease and from 9.8% to 6.3% for HPV-negative disease. Factors associated with surgery included younger age, health insurance, and treatment at academic centers.
Conclusions: In HPV-positive and HPV-negative disease, the percentage of locally advanced OPSCC undergoing surgery-based therapy has decreased.
(© 2021 Wiley Periodicals LLC.)
References: Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. https://doi.org/10.3322/canjclin.55.2.74.
de Almeida JR, Li R, Magnuson JS, et al. Oncologic outcomes after transoral robotic surgery: a multi-institutional study. JAMA Otolaryngol Head Neck Surg. 2015;141(12):1043-1051. https://doi.org/10.1001/jamaoto.2015.1508.
Cohen MA, Weinstein GS, O'Malley BW Jr, Feldman M, Quon H. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck. 2011;33(4):573-580. https://doi.org/10.1002/hed.21500.
Cracchiolo JR, Baxi SS, Morris LG, et al. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base. Cancer. 2016;122(10):1523-1532. https://doi.org/10.1002/cncr.29938.
Chen AY, Zhu J, Fedewa S. Temporal trends in oropharyngeal cancer treatment and survival: 1998-2009. Laryngoscope. 2014;124(1):131-138. https://doi.org/10.1002/lary.24296.
Zhan KY, Puram SV, Li MM, et al. National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Cancer. 2020;126(6):1295-1305. https://doi.org/10.1002/cncr.32654.
Gal TJ, Slezak JA, Kejner AE, Chen Q, Huang B. Treatment trends in oropharyngeal carcinoma: surgical technology meets the epidemic. Oral Oncol. 2019;97:62-68. https://doi.org/10.1016/j.oraloncology.2019.08.007.
Liederbach E, Lewis CM, Yao K, et al. A contemporary analysis of surgical trends in the treatment of squamous cell carcinoma of the oropharynx from 1998 to 2012: a report from the national cancer database. Ann Surg Oncol. 2015;22(13):4422-4431. https://doi.org/10.1245/s10434-015-4560-x.
NCCN Clinical practice guidelines: head and neck cancers. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
Albergotti WG, Gooding WE, Kubik MW, et al. Assessment of surgical learning curves in transoral robotic surgery for squamous cell carcinoma of the oropharynx. JAMA Otolaryngol Head Neck Surg. 2017;143(6):542-548. https://doi.org/10.1001/jamaoto.2016.4132.
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35. https://doi.org/10.1056/NEJMoa0912217.
Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24(17):2606-2611. https://doi.org/10.1200/JCO.2006.06.1291.
Brizel DM. Different strokes for different folks: new paradigms for staging oropharynx cancer. J Clin Oncol. 2015;33(8):817-818. https://doi.org/10.1200/JCO.2014.60.1757.
Vainshtein JM, Spector ME, McHugh JB, et al. Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. Oral Oncol. 2014;50(5):513-519. https://doi.org/10.1016/j.oraloncology.2014.02.001.
Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol. 2019;20(10):1349-1359. https://doi.org/10.1016/S1470-2045(19)30410-3.
Yeh DH, Tam S, Fung K, et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma-a systematic review of the literature. Eur J Surg Oncol. 2015;41(12):1603-1614. https://doi.org/10.1016/j.ejso.2015.09.007.
Yver CM, Shimunov D, Brody RM. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery. Oral Oncol. 2021;118:105307. https://doi.org/10.1016/j.oraloncology.2021.105307.
Amini A, Jasem J, Jones BL, et al. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Oral Oncol. 2016;56:1-7. https://doi.org/10.1016/j.oraloncology.2016.02.011.
Culié D, Viotti J, Modesto A, et al. Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study. Eur J Surg Oncol. 2020;47:367-374. https://doi.org/10.1016/j.ejso.2020.07.034.
Sload R, Silver N, Jawad BA, Gross ND. The role of transoral robotic surgery in the management of HPV negative oropharyngeal squamous cell carcinoma. Curr Oncol Rep. 2016;18(9):53. https://doi.org/10.1007/s11912-016-0541-x.
Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136(11):1079-1085. https://doi.org/10.1001/archoto.2010.191.
فهرسة مساهمة: Keywords: chemoradiation; human papillomavirus; oropharynx; squamous cell carcinoma; transoral robotic surgery
تواريخ الأحداث: Date Created: 20210909 Date Completed: 20211028 Latest Revision: 20211028
رمز التحديث: 20221213
DOI: 10.1002/hed.26860
PMID: 34499392
قاعدة البيانات: MEDLINE
الوصف
تدمد:1097-0347
DOI:10.1002/hed.26860